SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) (100µg) (Special Terms Apply*)
SARS-CoV-2 RBD-Nucleoprotein Chimera, His-Tag (CHO) (100µg) (Special Terms Apply*) (QTXAG-673-100) is SARS-CoV-2 RBD-Nucleoprotein Chimera, recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSa (human serum albumin), expressed in CHO cells using a C-terminal His-tag. These proteins can be used as diagnostic standard antigens, targets of neutralizing antibodies and in assay development for the detection and quantification of SARS-CoV-2 spike and nucleocapsid protein from recombinant or biological samples. Stronger binding affinity than that of individual S and N and only one test required to capture both anti-S and anti-N antibodies. Suitable for R&D of SARS-CoV-2 antibody detection tests. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
SARS-CoV-2 RBD-Nucleoprotein Chimera, recombinant SAR-CoV-2 N-terminal Spike S1 RBD (319-541) fused to full-length Nucleoprotein (Nucleocapsid) with a linker HSA (human serum albumin), expressed in CHO cells using a C-terminal His-tag. These proteins can be used as diagnostic standard antigens, targets of neutralizing antibodies and in assay development for the detection and quantification of SARS-CoV-2 spike and nucleocapsid protein from recombinant or biological samples. Stronger binding affinity than that of individual S and N and only one test required to capture both anti-S and anti-N antibodies. Suitable for R&D of SARS-CoV-2 antibody detection tests *Special Terms: Please see product specification details below and our Ordering page for details.
